English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Gene-edited seed developer Cibus officially withdraws $100 million IPOqrcode

May. 27, 2019

Favorites Print
Forward
May. 27, 2019

Cibus
United States  United States
Follow

Cibus, which is developing gene-edited crop traits for the global seed industry, officially withdrew its plans for an initial public offering on Friday. It had filed to raise $100 million by offering 6.7 million shares at a price range of $14 to $16.
 
The San Diego, CA-based company was founded in 2001 and booked $3 million in sales for the 12 months ended September 30, 2018. It had planned to list on the Nasdaq under the symbol CBUS. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray were set to be the joint bookrunners on the deal.

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe AgroNews Daily Alert to send news related to your mailbox